Sharma, S.K. et al. Inactivation and clearance of an anti-CEA carboxypeptidease G2 conjugate in blood after localization in a xenograft model. Br. J. Cancer, 61: 659-662, 1990.* |
Axworthy et al., “Antibody Pretargeting For Radioimmunotherapy: A Three-Step Approach In Tumored Nude Mice,” The Journal Of Nuclear Medicine; Proceedings Of The 39th Annual Meeting 33: p. 880, Abstract No. 234, 1992. |
Basch et al, Journal of Immunological Methods, 56:269-280, 1983. |
Bodenmuller et al, EMBO J., 5(8): 1825-9, 1986 (abstract only). |
Boehringer Mannheim Catalog-1991, pp. 49 and 59. |
E. A. L. Biessen et al, J. Med. Chem., “Synthesis of Cluster Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor”, vol. 38, No. 9, (1995), pp. 1538-1546. |
G. Paganelli, Nucl. Med. Comm., “Monoclonal Antibody Pretargetting Techniques for Tumor Localization: The Avidin-Biotin System”, vol. 12, (1991), pp. 211-234. |
Galli et al., “A Radiopharmaceutical For The Study Of The Liver: 99m Tc-DTPA-Asialo-Orosomucoid. II: Human Dynamic and Imaging Studies,” Journal Of Nuclear Medicine And Allied Sciences 32: 117-126, 1988. |
Galli et al., J. Nucl. Med., vol. 32, No. 2, pp. 110-116, 1988, “A Radiopharmaceutical for the Study of the Liver: 99m-Tc-DTPA-AsialoOrosomucoid I: Radiochemical and Animal Distribution Studies.”. |
Goodwin et al., J. Nucl. Med., p. 880, 1992, Abstract No. 232, “Pharmacokinetics of Biotin-Chelate Conjugates for Pretargeted Avidin-Biotin Immunoscintigraphy.”. |
Goodwin, J. Nucl. Med., vol. 33, No. 10, pp. 1816-1818, 1992, “New Methods for Localizing Infection: A role for Avidin-Biotin?”. |
Goodwin/Hnatowich, J. Nucl. Med., vol. 32, No. 4, pp. 750-751, 1991, Letter to the Editor/Reply. |
I. S. Krull et al, J. Chromatography B: Biomedical Applications, “Solid-phase derivatization reactions for biomedical liquid chromatography”, 659 (1994), pp. 19-50. |
J. Mattes, J. Natl. Canc. Instit., “Biodistribution of Antibodies After Intraperitoneal or Intravenous Injection and Effect of Carbohydrate Modifications”, vol. 79, No. 4, Oct. 1, 1987, pp. 855-863. |
J. R. Merwin et al, Bioconjugate Chem., “Targeted Delivery of DNA Using YEE(GalNAcAH)(3), a synthetic Glycopeptide Ligand for the Asialoglycoprotein Receptor”, vol. 5 (1994), 612-620. |
Koch and Macke, Angew. Chem. Intl. Ed. Engl., vol. 31, No. 11, pp. 1507-1509, 1992, 99m Tc Labeled Biotin Conjugate in a Tumor ‘Pretargeting’ Approach with Monoclonal Antibodies. |
Krantz et al., Biochemistry, vol. 15, No. 18, pp. 3963-3968, 1976, “Attachment of Thioglycosides to Proteins: Enhancement of Liver Membrane Binding.”. |
Lee et al., Biochemistry, vol. 15, No. 18, pp. 3956-3962, 1976, “2-1mino-2-methoxyethyl 1-Thioglycosides: New Reagents for Attachment Sugars to Proteins.”. |
M. A. Findeis, Int. J. Peptide Protein Res., “Stepwise synthesis of Ga1NAc-containing cluster glycoside ligand of the asialoglycoprotein receptor”, vol. 43, (1994), pp. 477-485. |
Manger et al Biochemistry (1992) 31 pp. 10733-10740. |
Paganelli et al., Int. J. Cancer, 45:1184-1189, 1990, “Intraperitoneal Radio-Localization of Tumors Pre-Targeted by Biotinylated Monoclonal Antibodies.”. |
Paganelli et al., Nuclear Medicine Communications, 12:211-234, 1991, “Monoclonal antibody pretargeting techniques for tumour localization: the avidin-biotin system.”. |
Peter van der Sluijs et al, Hepatology, “Drug Targeting to the Liver with Lactosylated Albumins: Does the Glycoprotein Target the Drug or is the Drug Targeting the Glycoprotein?”, vol. 6, No. 7, (1986), pp. 723-728. |
Pierce Biochemicals—Immunotechnology vol. 1, .COPYRGT. 1990. |
R. T. Lee et al, Biochemistry, “New Synthetic Cluster Ligands for Galactose/N-Acetylgalactosamine-Specific Lectin of Mammalian Liver”, vol. 23, (1984), pp. 4255-4261. |
R. T. Lee et al, Glycoconjugate, “Preparation of Cluster Glycosides of N-Acetygalactosamine That Have Subnanomolar Binding Constants Towards the Mammalian Hepatic Ga1/Ga1NAc-specific Receptor”, vol. 4, (1987), pp. 317-328. |
R. W. Jansen et al, J. Biol. Chem., “Hepatic Endocytosis of Various Types of Mannose-Terminated Albumins”, vol. 266, No. 5, Feb. 15, 1991, pp. 3343-3348. |
Rosario et al., J. Nucl. Med., vol. 32, No. 5, p. 993, 1991, Abstract No. 356, “Bolton-Hunter and Biotin Derivatized Polylysine: A New Multi-Valent Peptide Reagent for In Vivo Pre-Targeting with Streptavidin Conjugates.”. |
Sanderson et al., “Preparation And Characterization Of Biotin Conjugates Of Anti-Pan-Carcinoma NR-LU-10 Monoclonal Antibody For A Three Step Radioimmunotherapy,” The Journal Of Nuclear Medicine; Proceedings Of The 39 (Λth) Annual Meeting 33: p. 880, Abstract No. 233, 1992. |
Sharon and Lis, Scientific American, vol. 268, No. 1, pp. 82-89, 1993, “Carbohydrates in Cell Recognition.”. |
Sheldon et al., Appl. Radiat. Isot., vol. 43, No. 11, pp. 1399-1402, 1992, “Targeting of [111 In] Biocytin to Cultured Ovarian Adenocarcinoma Cells Using Covalent Monoclonal Antibody-Streptavidin Conjugates.”. |
Sigma Cataloque .COPYRGT.1984, p. 250. |
T. D. McKee et al, Bioconjugate Chem., “Preparation of Asialoorosomucoid-Polylysine Conjugates”, vol. 5, (1994), pp. 306-311. |
Tolleshaug, Int. J. Biochem., vol. 13, pp. 45-51, 1981, “Binding and Internalization of Asialoglycoproteins by Isolated Rat Hepatocytes.”. |
Virzi et al., J. Nucl. Med., p. 920, 1992, Abstract No. 403, “The Preparation and Evaluation of 12 Biotin Derivatives Labeled with Tc-99M.”. |